Diabetic eye disease trials in Germany

In Germany 7 Also abroad 142

7 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
Where
Bonn, Mainz, Neubrandenburg, Tuebingen, Ulm
Age
18 years and over
People
175 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06321302 · EU 2023-508891-12-00
Phase 2Taking people
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
Where
Dresden, Duesseldorf, Leipzig, Mannheim, Munster
Age
18 years and over
People
300 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06962839 · EU 2024-520384-14-00
No phaseTaking people
AI Screening for Diabetic Retinopathy
Where
Düsseldorf
Age
18 years and over
People
100
Run by
West German Center of Diabetes and Health
See details and how to joinNCT05704491
No phaseTaking people
DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. The Project Also Explores New Ways to Collect and Use Publicly Available Healthcare Information.
Where
Leverkusen
Age
18 years and over
People
50,000
Run by
Bayer
See details and how to joinNCT07308639
No phaseEnrolling by invitation
Artificial-Intelligence-based Early Detection of Diabetic Retinopathy (FUNDUS AI)
Where
Tübingen
Age
18 years to 80 years
People
100
Run by
University Hospital Tuebingen
See details and how to joinNCT07378891
No phaseTaking people
Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)
Where
Düsseldorf
Age
18 years and over
People
200
Run by
Heinrich-Heine University, Duesseldorf
See details and how to joinNCT06124586
Phase 2Taking people
Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein Occlusion
Where
Tuebingen
Age
18 years and over
People
12 worldwide
Run by
Annexin Pharmaceuticals AB
See details and how to joinNCT07259928 · EU 2026-525349-65-00